Connection

Pierre Giglio to Receptor, Fibroblast Growth Factor, Type 3

This is a "connection" page, showing publications Pierre Giglio has written about Receptor, Fibroblast Growth Factor, Type 3.
  1. Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Clin Cancer Res. 2022 06 01; 28(11):2270-2277.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.